Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dewi Harjanto

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Genome Medicine|August 15, 2020
Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopesAsaf Poran, Dewi Harjanto, Matthew Malloy, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2017
Loss of APOBEC1 RNA-editing function in microglia exacerbates age-related CNS pathophysiologyDaniel C Cole, Youngcheul Chung, Khatuna Gagnidze, et al.
Cell Reports Methods|February 23, 2023
A universal MHCII technology platform to characterize antigen-specific CD4<sup>+</sup> T cellsRohit Vyasamneni, Victoria Kohler, Binisha Karki, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2024
APOBEC2 safeguards skeletal muscle cell fate through binding chromatin and regulating transcription of non-muscle genes during myoblast differentiationJ Paulo Lorenzo, Linda Molla, Elias Moris Amro, et al.
Cell|May 10, 2023
The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infectionChristina M Arieta, Yushu Joy Xie, Daniel A Rothenberg, et al.
Immunity|September 10, 2019
Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope PredictionJennifer G Abelin, Dewi Harjanto, Matthew Malloy, et al.
Immunity|February 10, 2021
Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope predictionJennifer G Abelin, Dewi Harjanto, Matthew Malloy, et al.
Cell|October 16, 2020
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder CancerPatrick A Ott, Siwen Hu-Lieskovan, Bartosz Chmielowski, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Genome Medicine|August 15, 2020
Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopesAsaf Poran, Dewi Harjanto, Matthew Malloy, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2017
Loss of APOBEC1 RNA-editing function in microglia exacerbates age-related CNS pathophysiologyDaniel C Cole, Youngcheul Chung, Khatuna Gagnidze, et al.
Cell Reports Methods|February 23, 2023
A universal MHCII technology platform to characterize antigen-specific CD4<sup>+</sup> T cellsRohit Vyasamneni, Victoria Kohler, Binisha Karki, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2024
APOBEC2 safeguards skeletal muscle cell fate through binding chromatin and regulating transcription of non-muscle genes during myoblast differentiationJ Paulo Lorenzo, Linda Molla, Elias Moris Amro, et al.
Cell|May 10, 2023
The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infectionChristina M Arieta, Yushu Joy Xie, Daniel A Rothenberg, et al.
Immunity|September 10, 2019
Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope PredictionJennifer G Abelin, Dewi Harjanto, Matthew Malloy, et al.
Immunity|February 10, 2021
Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope predictionJennifer G Abelin, Dewi Harjanto, Matthew Malloy, et al.
Cell|October 16, 2020
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder CancerPatrick A Ott, Siwen Hu-Lieskovan, Bartosz Chmielowski, et al.
Pageof 2